Medical Health & Life Science Research News

New report examines the electrophysiology market

Medical Market Research

Catheter ablation is highly preferred device due to its minimal invasive nature and is designated as ‐gold standard‐ modality for treating atrial fibrillation. The growing adoption of this device by the physicians or electrophysiologists has catered double digit growth in the study period.

The global electrophysiology market size was $3,420 million in 2015, and is expected to reach $8,271 million by 2022, while growing at a CAGR of 13.4% from 2016 to 2022. Electrophysiology (EP) is the branch of cardiology that deals with the diagnosis and treatment of heart rhythm disorders.


EP ablation is a minimally invasive procedure, which employs catheters to destroy faulty electrical pathways from heart. The device is useful in removal of the abnormal heart tissues that cause irregular heart rhythms.

Radiofrequency and cryoablation types are the most widely used EP ablation catheters, and are expected to register significant market capture with pertinent advancements in the technology. In addition, the number of ablation procedures performed for the treatment of atrial fibrillation is expected to increase substantially in the foresee future.

Catheter ablation is a low-risk process with high success rates, making it the most preferred modality for the treatment of cardiac arrhythmias. The treatment of cardiac arrhythmias, especially atrial fibrillation, by cardiac ablation is the potential target area for investment by the key players in this segment.



The atrial fibrillation application accounted for the majority market share in 2015. The cryoablation segment is poised to grow at a CAGR of 15.1% from 2016 to 2022.

This growth is attributed to the elimination of disadvantages related with radiofrequency ablation, such as burns of RF, that disrupts the endothelium, tamponades, thromboembolic strokes, and atrial-oesophageal fistula. Moreover, cryoablation catheter ablation and laser ablation is a low-risk process with high success rates, making it a most preferred treatment modality for cardiac arrhythmias.

The market is driven by growth in incidence of atrial fibrillation (one of the most common heart rhythm disorder or cardiac arrhythmia), growth in baby boomer generation with high-risk of targeted diseases, and increase in adoption of EP catheter ablation. Rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, bidirectional duodecapolar diagnostic catheter, remote steering systems, and irrigated-tip RF catheters), and growth in EP labs further drives the market growth.

However, stringent government regulations, high cost of the treatment of complex arrhythmias, preference to pharmaceutical interventions (drugs) over, and dearth of skilled & experienced electrophysiologists restrain the market growth.


  • EP Ablation Catheters 
  • Cryoablation EP Catheters
  • Radiofrequency Ablation Catheters
  • Irrigated-tip Radiofrequency Ablation Catheters
  • Conventional Radiofrequency Ablation Catheters
  • Microwave Ablation Systems
  • Laser Ablation Systems
  • Navigational Advanced Mapping Accessories

Report at:


News From

Allied Market Research - Powering Enterprises through Business IntelligenceAllied Market Research
Category: Market Research Publishers and RetailersCompany about: Allied Market Research is a global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market dom ...
This email address is being protected from spambots. You need JavaScript enabled to view it.